Trial · NCT02439320
Results by group43
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 43
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants Who Are Headache Pain Free | 100 mg Lasmiditan | 28.2 | percentage of participants | ||
| Percentage of Participants Who Are Headache Pain Free | 200 mg Lasmiditan | 32.2 | percentage of participants | ||
| Percentage of Participants Who Are Headache Pain Free | Placebo | 15.3 | percentage of participants | ||
| Percentage of Participants Who Are Most Bothersome Symptom (MBS) Free | 100 mg Lasmiditan | 40.9 | percentage of participants | ||
| Percentage of Participants Who Are Most Bothersome Symptom (MBS) Free | 200 mg Lasmiditan | 40.7 | percentage of participants | ||
| Percentage of Participants Who Are Most Bothersome Symptom (MBS) Free | Placebo | 29.5 | percentage of participants | ||
| Percentage of Participants Who Have Headache Relief After First Dose | 100 mg Lasmiditan | 59.4 | percentage of participants | ||
| Percentage of Participants Who Have Headache Relief After First Dose | 200 mg Lasmiditan | 59.5 | percentage of participants | ||
| Percentage of Participants Who Have Headache Relief After First Dose | Placebo | 42.2 | percentage of participants | ||
| Percentage of Participants With Headache Recurrence | 100 mg Lasmiditan | 8.4 | percentage of participants | ||
| Percentage of Participants With Headache Recurrence | 200 mg Lasmiditan | 10.1 | percentage of participants | ||
| Percentage of Participants With Headache Recurrence | Placebo | 5.1 | percentage of participants | ||
| Percentage of Participants Who Used Rescue Medication | 100 mg Lasmiditan | 26.2 | percentage of participants | ||
| Percentage of Participants Who Used Rescue Medication | 200 mg Lasmiditan | 20.7 | percentage of participants | ||
| Percentage of Participants Who Used Rescue Medication | Placebo | 46.0 | percentage of participants | ||
| Percentage of Participants Who Used Rescue Medication | 100 mg Lasmiditan | 8.9 | percentage of participants | ||
| Percentage of Participants Who Used Rescue Medication | 200 mg Lasmiditan | 7.9 | percentage of participants | ||
| Percentage of Participants Who Used Rescue Medication | Placebo | 11.7 | percentage of participants | ||
| Percentage of Participants Who Used Rescue Medication | 100 mg Lasmiditan | 0 | percentage of participants | ||
| Percentage of Participants Who Used Rescue Medication | 200 mg Lasmiditan | 0 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02439320/results